Gut microbiota derived DCA enhances FOLFOX efficacy via Ugt1a6b mediated enterohepatic circulation in colon cancer
FOLFOX (5-Fluorouracil, Calcium Folinate combined with Oxaliplatin) is a preferred chemotherapy regimen for colon cancer, but its limited efficacy remains a major challenge, significantly impairs patient outcomes. There is an urgent need to identify strategies to improve its therapeutic effectivenes...
Saved in:
Main Authors: | Qian Fang, Xiaoying Hou, Limei Fan, Yufei Deng, Xiaoxuan Li, Hongyun Zhang, Haiping Wang, Zhengqi Fu, Binlian Sun, Xiji Shu, Hongzhi Du, Yuchen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825000611 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers
by: Xiufen Zheng, et al.
Published: (2025-01-01) -
La socialización frustrada de la industria del Calzado en Barcelona (1936-1939)
by: Joël Delhom
Published: (2023-07-01) -
Combination of Gilbert's syndrome and gastrointestinal diseases
by: G. M. Dubrovina, et al.
Published: (2014-09-01) -
Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
by: Luiz Carlos Porcello Marrone, et al.
Published: (2013-01-01) -
Model-Based Detection of Coordinated Attacks (DCA) in Distribution Systems
by: Nitasha Sahani, et al.
Published: (2024-01-01)